Systematic misclassification of missense variants in BRCA1 and BRCA2 “coldspots”

Abstract

In BRCA1 and BRCA2 coldspots, missense variants are very unlikely to be pathogenic. Classification schemes that incorporate coldspots can reduce the number of VUS and mitigate risks from reporting benign variation as VUS.